The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Evolem Start, startups are often financed by Pertinence Invest, KREAXI, Axeleo. The meaningful sponsors for the fund in investment in the same round are Axeleo, Omnes Capital, KREAXI.
The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight BLIINK, Tilkee. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Business Intelligence, CRM.
Deals in the range of 1 - 5 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The high activity for fund was in 2018.
Related Funds
Funds with similar focus
Fund Name | Location |
Barclays Investment Bank | Atlanta, Georgia, United States |
Biomec | Cleveland, Ohio, United States |
BVF Partners | California, San Francisco, United States |
Cambridge Capital | Florida, United States, West Palm Beach |
Caspark | Beijing, China, Haidian |
Christavest | - |
Derbaix Ventures | Community of Madrid, Madrid, Spain |
Everbright Securities | China, Shanghai |
Gemcorp | England, London, United Kingdom |
Goodgrower | Community of Madrid, Madrid, Spain |
Grupo Pegasus | - |
Highlander Partners | Dallas, Texas, United States |
iStart | - |
Lighthouse Capital Group | California, Long Beach, United States |
NewWorld Capital Group LLC | New York, New York, United States |
PROTO Japan | Aichi Prefecture, Japan, Nagoya |
Watson Pharmaceuticals | California, Corona, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
NectarGo | $2M | 18 Jun 2024 | Lille, Nord-Pas-de-Calais, France | ||
Kolus | $708K | 05 Jun 2024 | Lyon, Rhone-Alpes, France | ||
Sopht | $3M | 04 Jun 2024 | - | ||
Abraxio | $2M | 17 Apr 2024 | Lyon, Rhone-Alpes, France | ||
Kor | $4M | 03 Apr 2024 | Paris, Ile-de-France, France | ||
Crealo | $1M | 18 Jan 2024 | Neuilly-sur-seine, Ile-de-France, France | ||
Promyze | $1M | 17 Nov 2023 | Bordeaux, Aquitaine, France | ||
Obat | $14M | 15 Nov 2023 | Nantes, Pays de la Loire, France | ||
Jimini AI | $2M | 13 Nov 2023 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
NectarGo | $2M | 18 Jun 2024 | Lille, Nord-Pas-de-Calais, France | ||
Kolus | $708K | 05 Jun 2024 | Lyon, Rhone-Alpes, France | ||
Sopht | $3M | 04 Jun 2024 | - | ||
Abraxio | $2M | 17 Apr 2024 | Lyon, Rhone-Alpes, France | ||
Kor | $4M | 03 Apr 2024 | Paris, Ile-de-France, France | ||
Crealo | $1M | 18 Jan 2024 | Neuilly-sur-seine, Ile-de-France, France | ||
Promyze | $1M | 17 Nov 2023 | Bordeaux, Aquitaine, France | ||
Obat | $14M | 15 Nov 2023 | Nantes, Pays de la Loire, France | ||
Jimini AI | $2M | 13 Nov 2023 | Paris, Ile-de-France, France |